DIANA OLIVERA: Open Payments
NPI 1841782265 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 15 payments from 7 companies in 2025. Trend: 2023 $896 · 2024 $809 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 7 | $205 |
| Sumitomo Pharma America, Inc. | 2 | $53 |
| Astellas Pharma US Inc | 2 | $41 |
| Hologic Sales and Service, LLC | 1 | $38 |
| IBSA Pharma Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $16 |
Products named: TWIRLA, MYFEMBREE, Veozah, ACESSA PROVU SYSTEM, SLYND, Tirosint, Cologuard Collection Kit, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
